ArticleResearch square2025
A robust and powerful GWAS method for family trios supporting within-family Mendelian randomization analysis.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Effect size estimates in genome-wide association studies (GWAS) and Mendelian randomization (MR) studies for independent individuals may be biased due to dynastic effect (DE) and residual population stratification (RPS). Existing GWAS methods for family trios effectively controlled such biases, while only using parental and offspring's genotypes and offspring's phenotype, and not incorporating parental phenotypes, which causes loss in estimation accuracy and test power. Therefore, we proposed a novel GWAS method based on structural equation modelling for family trios, denoted by FT-SEM. FT-SEM simultaneously uses parental and offspring's genotypes and phenotypes. Simulation results demonstrate that FT-SEM substantially improves estimation accuracy and test power while controlling bias and type I error rate. Using family trios from Minnesota Center for Twin and Family Research (MCTFR), we found that DE and RPS greatly distort the results only based on independent individuals, and FT-SEM effectively corrects such biases. Combining the GWAS results from MCTFR with existing summary data, we performed several two-sample MR analyses. We observed that the effects of BMI on nicotine, alcohol consumption and behavior disorder were due to bias rather than causality. Our findings underscore the necessity of using families to validate the results of GWAS and MR, and highlight FT-SEM's advantages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.